Literature DB >> 17230545

Transradial approach for carotid artery stenting: a feasibility study.

Jessica Folmar1, Ravish Sachar, Tift Mann.   

Abstract

BACKGROUND: Carotid artery stenting (CAS) has become accepted as an alternative to carotid endarterectomy for revascularization of the internal carotid artery (ICA) among high risk patients. CAS from the femoral approach can be problematic due to access site complications as well as technical difficulties related to peripheral vascular disease (PVD) and/or anatomical variations of the aortic arch. The purpose of the present study is to evaluate the feasibility of the radial artery as an alternative approach for CAS.
METHODS: Forty-two patients (mean age 71 +/- 1, 26 male) underwent CAS. All had a CA stenosis greater than 80% and comorbid conditions increasing the risk of carotid endarterectomy. The target common carotid artery (CCA) was initially cannulated via the radial artery using a 5F Simmons 1 diagnostic catheter which was then advanced to the external CA (ECA) over an extra support 0.014" coronary guidewire. After removing the coronary guidewire, a 0.035" guidewire was advanced into the ECA, and the Simmons 1 was exchanged for a 5F or 6F shuttle sheath and positioned in the distal CCA. In four patients with a bovine aortic arch, the left CCA was accessed with a 5F Amplatz R2 catheter which was then exchanged for a shuttle sheath over a 0.035" guidewire. CAS was performed using standard techniques with weight-based bivalirudin for anticoagulation.
RESULTS: CAS was successful in 35/42 (83%) patients, including 28/29 (97%) right CA, 4/5 (80%) bovine left CA, 7/13 (54%) left CA. Mean interventional time was 30 +/- 3 minutes. The sheath was removed immediately after the procedure. There were no radial access site complications. One patient sustained a stroke 24 hrs after the procedure with complete resolution of symptoms (Mean NIH stroke scale 2.0 +/- 0.3 before, 1.9 +/- 0.3 after). Median hospital stay was 2 +/- 0.6 days. Inadequate catheter support at the origin of the CCA was the technical cause of failure in the seven unsuccessful cases.
CONCLUSION: CAS using the transradial approach appears to be safe and technically feasible. The technique may be particularly useful in patients with right ICA lesions and severe PVD or unfavorable arch anatomy, and among patients with a bovine aortic arch. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230545     DOI: 10.1002/ccd.21049

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Carotid artery stenting in difficult aortic arch anatomy with or without a new dedicated guiding catheter: preliminary experience.

Authors:  Giulio Barbiero; Diego Cognolato; Andrea Casarin; Rudi Stramanà; Elisa Galzignan; Alessandro Guarise
Journal:  Eur Radiol       Date:  2012-11-18       Impact factor: 5.315

Review 2.  Carotid Revascularization: Current Practice and Future Directions.

Authors:  Jacob H Bagley; Ryan Priest
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

3.  Transradial supra-aortic arteries interventions: a good option for elderly patients.

Authors:  Gianluca Rigatelli; Marco Zuin; Fabio Dell'Avvocata; Sara Giatti; Ramesh Daggubati
Journal:  J Geriatr Cardiol       Date:  2018-10       Impact factor: 3.327

4.  Clinical situations requiring radial or brachial access during carotid artery stenting.

Authors:  Damian R Maciejewski; Łukasz Tekieli; Mariusz Trystuła; Tomasz Tomaszewski; Roman Machnik; Jacek Legutko; Marek Kazibudzki; Robert Musiał; Marcin Misztal; Piotr Pieniążek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

5.  Distal radial artery (snuffbox) access for carotid artery stenting - Technical pearls and procedural set-up.

Authors:  Anna Luisa Kühn; Jasmeet Singh; Viraj M Moholkar; Sudhakar R Satti; Katyucia de Macedo Rodrigues; Francesco Massari; Matthew J Gounis; Archie McGowan; Ajit S Puri
Journal:  Interv Neuroradiol       Date:  2020-09-13       Impact factor: 1.610

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.